NKX2-1/TTF-1: An Enigmatic Oncogene that Functions as a Double-Edged Sword for Cancer Cell Survival and Progression

Cancer Cell

Volumn 23, Issue 6, 2013, Pages 718-723

  Yamaguchi, Tomoya ^a   Hosono, Yasuyuki ^a   Yanagisawa, Kiyoshi ^a   Takahashi, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.1; UNCLASSIFIED DRUG;

CANCER CELL; CANCER GROWTH; CELL SURVIVAL; HUMAN; LUNG CARCINOGENESIS; LUNG DEVELOPMENT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SHORT SURVEY; TRANSCRIPTION REGULATION;

EID: 84878965845     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.04.002     Document Type: Review

References (49)

1. Anagnostou V.K., Syrigos K.N., Bepler G., Homer R.J., Rimm D.L. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J. Clin. Oncol. 2009, 27:271-278.
2. Costa R.H., Kalinichenko V.V., Lim L. Transcription factors in mouse lung development and function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L823-L838.
3. Garraway L.A., Sellers W.R. Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 2006, 6:593-602.
4. Gudmundsson J., Sulem P., Gudbjartsson D.F., Jonasson J.G., Sigurdsson A., Bergthorsson J.T., He H., Blondal T., Geller F., Jakobsdottir M., et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 2009, 41:460-464.
5. Harris T., Pan Q., Sironi J., Lutz D., Tian J., Sapkar J., Perez-Soler R., Keller S., Locker J. Both gene amplification and allelic loss occur at 14q13.3 in lung cancer. Clin. Cancer Res. 2011, 17:690-699.
6. Homminga I., Pieters R., Langerak A.W., de Rooi J.J., Stubbs A., Verstegen M., Vuerhard M., Buijs-Gladdines J., Kooi C., Klous P., et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in Tcell acute lymphoblastic leukemia. Cancer Cell 2011, 19:484-497.
7. Hosono Y., Usukura J., Yamaguchi T., Yanagisawa K., Suzuki M., Takahashi T. MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility. Biochem. Biophys. Res. Commun. 2012, 428:173-178.
8. Hosono Y., Yamaguchi T., Mizutani E., Yanagisawa K., Arima C., Tomida S., Shimada Y., Hiraoka M., Kato S., Yokoi K., et al. MYBPH,a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J. 2012, 31:481-493.
9. Inzelberg R., Weinberger M., Gak E. Benign hereditary chorea: an update. Parkinsonism Relat. Disord. 2011, 17:301-307.
10. Kendall J., Liu Q., Bakleh A., Krasnitz A., Nguyen K.C., Lakshmi B., Gerald W.L., Powers S., Mu D. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc. Natl. Acad. Sci. USA 2007, 104:16663-16668.
11. Kunii R., Jiang S., Hasegawa G., Yamamoto T., Umezu H., Watanabe T., Tsuchida M., Hashimoto T., Hamakubo T., Kodama T., et al. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma. Histopathology 2011, 58:467-476.
12. Kwei K.A., Kim Y.H., Girard L., Kao J., Pacyna-Gengelbach M., Salari K., Lee J., Choi Y.L., Sato M., Wang P., et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008, 27:3635-3640.
13. Li C., Zhu N.L., Tan R.C., Ballard P.L., Derynck R., Minoo P. Transforming growth factor-β inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. J. Biol. Chem. 2002, 277:38399-38408.
14. Liu C., Glasser S.W., Wan H., Whitsett J.A. GATA-6 and thyroid transcription factor-1 directly interact and regulate surfactant protein-C gene expression. J. Biol. Chem. 2002, 277:4519-4525.
15. Maeda Y., Tsuchiya T., Hao H., Tompkins D.H., Xu Y., Mucenski M.L., Du L., Keiser A.R., Fukazawa T., Naomoto Y., et al. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. J. Clin. Invest. 2012, 122:4388-4400.
16. Minoo P., Su G., Drum H., Bringas P., Kimura S. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. Dev. Biol. 1999, 209:60-71.
17. Minoo P., Hu L., Xing Y., Zhu N.L., Chen H., Li M., Borok Z., Li C. Physical and functional interactions between homeodomain NKX2.1 and winged helix/forkhead FOXA1 in lung epithelial cells. Mol. Cell. Biol. 2007, 27:2155-2165.
18. Missero C., Pirro M.T., Di Lauro R. Multiple Ras downstream pathways mediate functional repression of the homeobox gene product TTF-1. Mol. Cell. Biol. 2000, 20:2783-2793.
19. Nagel S., Kaufmann M., Drexler H.G., MacLeod R.A. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res. 2003, 63:5329-5334.
20. Ngan E.S., Lang B.H., Liu T., Shum C.K., So M.T., Lau D.K., Leon T.Y., Cherny S.S., Tsai S.Y., Lo C.Y., et al. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J. Natl. Cancer Inst. 2009, 101:162-175.
21. Niimi T., Nagashima K., Ward J.M., Minoo P., Zimonjic D.B., Popescu N.C., Kimura S. claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol. Cell. Biol. 2001, 21:7380-7390.
22. Nishikawa E., Osada H., Okazaki Y., Arima C., Tomida S., Tatematsu Y., Taguchi A., Shimada Y., Yanagisawa K., Yatabe Y., et al. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 2011, 71:6165-6173.
23. Osada H., Tatematsu Y., Yatabe Y., Horio Y., Takahashi T. ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res. 2005, 65:10680-10685.
24. Osada H., Tomida S., Yatabe Y., Tatematsu Y., Takeuchi T., Murakami H., Kondo Y., Sekido Y., Takahashi T. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res. 2008, 68:1647-1655.
25. Park K.S., Whitsett J.A., Di Palma T., Hong J.H., Yaffe M.B., Zannini M. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J. Biol. Chem. 2004, 279:17384-17390.
26. Qi J., Rice S.J., Salzberg A.C., Runkle E.A., Liao J., Zander D.S., Mu D. MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle 2012, 11:177-186.
27. Ramirez M.I., Rishi A.K., Cao Y.X., Williams M.C. TGT3, thyroid transcription factor I, and Sp1 elements regulate transcriptional activity of the 1.3-kilobase pair promoter of T1α, a lung alveolar type I cell gene. J. Biol. Chem. 1997, 272:26285-26294.
28. Runkle E.A., Rice S.J., Qi J., Masser D., Antonetti D.A., Winslow M.M., Mu D. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1). J. Biol. Chem. 2012, 287:28790-28801.
29. Saito R.A., Watabe T., Horiguchi K., Kohyama T., Saitoh M., Nagase T., Miyazono K. Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 2009, 69:2783-2791.
30. Snyder E.L., Watanabe H., Magendantz M., Hoersch S., Chen T.A., Wang D.G., Crowley D., Whittaker C.A., Meyerson M., Kimura S., Jacks T. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol. Cell 2013, Published online March 19, 2013. 10.1016/j.molcel.2013.02.018.
31. Stahlman M.T., Gray M.E., Whitsett J.A. Expression of thyroidtranscription factor-1 (TTF-1) in fetal and neonatal human lung. J. Histochem. Cytochem. 1996, 44:673-678.
32. Stanfel M.N., Moses K.A., Schwartz R.J., Zimmer W.E. Regulation of organ development by the NKX-homeodomain factors: an NKX code. Cell. Mol. Biol. (Noisy-le-grand) 2005, (Suppl 51):OL785-OL799.
33. Tagne J.B., Gupta S., Gower A.C., Shen S.S., Varma S., Lakshminarayanan M., Cao Y., Spira A., Volkert T.L., Ramirez M.I. Genome-wide analyses of Nkx2-1 binding to transcriptional target genes uncover novel regulatory patterns conserved in lung development and tumors. PLoS One 2012, 7:e29907.
34. Takeuchi T., Tomida S., Yatabe Y., Kosaka T., Osada H., Yanagisawa K., Mitsudomi T., Takahashi T. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J. Clin. Oncol. 2006, 24:1679-1688.
35. Tanaka H., Yanagisawa K., Shinjo K., Taguchi A., Maeno K., Tomida S., Shimada Y., Osada H., Kosaka T., Matsubara H., et al. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res. 2007, 67:6007-6011.
36. Watanabe H., Francis J.M., Woo M.S., Etemad B., Lin W., Fries D.F., Peng S., Snyder E.L., Tata P.R., Izzo F., et al. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes Dev. 2013, 27:197-210.
37. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., Lin W.M., Province M.A., Kraja A., Johnson L.A., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898.
38. Wert S.E., Dey C.R., Blair P.A., Kimura S., Whitsett J.A. Increased expression of thyroid transcription factor-1 (TTF-1) in respiratory epithelial cells inhibits alveolarization and causes pulmonary inflammation. Dev. Biol. 2002, 242:75-87.
39. Winslow M.M., Dayton T.L., Verhaak R.G., Kim-Kiselak C., Snyder E.L., Feldser D.M., Hubbard D.D., DuPage M.J., Whittaker C.A., Hoersch S., et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 2011, 473:101-104.
40. Yamaguchi T., Yanagisawa K., Sugiyama R., Hosono Y., Shimada Y., Arima C., Kato S., Tomida S., Suzuki M., Osada H., Takahashi T. NKX2-1/TITF1/TTF-1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 2012, 21:348-361.
41. Yan C., Whitsett J.A. Protein kinase A activation of the surfactant protein B gene is mediated by phosphorylation of thyroid transcription factor 1. J. Biol. Chem. 1997, 272:17327-17332.
42. Yan C., Naltner A., Conkright J., Ghaffari M. Protein-protein interaction of retinoic acid receptor α and thyroid transcription factor-1 in respiratory epithelial cells. J. Biol. Chem. 2001, 276:21686-21691.
43. Yan C., Naltner A., Martin M., Naltner M., Fangman J.M., Gurel O. Transcriptional stimulation of the surfactant protein B gene by STAT3 in respiratory epithelial cells. J. Biol. Chem. 2002, 277:10967-10972.
44. Yang L., Yan D., Bruggeman M., Du H., Yan C. Mutation of alysine residue in a homeodomain generates dominant negative thyroid transcription factor 1. Biochemistry 2004, 43:12489-12497.
45. Yatabe Y., Mitsudomi T., Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am. J. Surg. Pathol. 2002, 26:767-773.
46. Yatabe Y., Kosaka T., Takahashi T., Mitsudomi T. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am. J. Surg. Pathol. 2005, 29:633-639.
47. Yin Z., Gonzales L., Kolla V., Rath N., Zhang Y., Lu M.M., Kimura S., Ballard P.L., Beers M.F., Epstein J.A., Morrisey E.E. Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L191-L199.
48. Yuan B., Li C., Kimura S., Engelhardt R.T., Smith B.R., Minoo P. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev. Dyn. 2000, 217:180-190.
49. Zhou B., Zhong Q., Minoo P., Li C., Ann D.K., Frenkel B., Morrisey E.E., Crandall E.D., Borok Z. Foxp2 inhibits Nkx2.1-mediated transcription of SP-C via interactions with the Nkx2.1 homeodomain. Am. J. Respir. Cell Mol. Biol. 2008, 38:750-758.